<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
      <PMID Version="1">33446327</PMID>
      <DateCompleted>
        <Year>2021</Year>
        <Month>02</Month>
        <Day>18</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2021</Year>
        <Month>02</Month>
        <Day>18</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">0035-3787</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>177</Volume>
            <Issue>1-2</Issue>
            <PubDate>
              <Year>2021</Year>
              <Season>Jan-Feb</Season>
            </PubDate>
          </JournalIssue>
          <Title>Revue neurologique</Title>
          <ISOAbbreviation>Rev Neurol (Paris)</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Neurological manifestations associated with SARS-CoV-2 and other coronaviruses: A narrative review for clinicians.</ArticleTitle>
        <Pagination>
          <StartPage>51</StartPage>
          <EndPage>64</EndPage>
          <MedlinePgn>51-64</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.neurol.2020.10.001</ELocationID>
        <ELocationID EIdType="pii" ValidYN="Y">S0035-3787(20)30732-3</ELocationID>
        <Abstract>
          <AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">The past two decades have been marked by three epidemics linked to emerging coronaviruses. The COVID-19 pandemic highlighted the existence of neurological manifestations associated with SARS-CoV-2 infection and raised the question of the neuropathogenicity of coronaviruses. The aim of this review was to summarize the current data about neurological manifestations and diseases linked to human coronaviruses.</AbstractText>
          <AbstractText Label="MATERIAL AND METHODS" NlmCategory="METHODS">Articles have been identified by searches of PubMed and Google scholar up to September 25, 2020, using a combination of coronavirus and neurology search terms and adding relevant references in the articles.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">We found five cohorts providing prevalence data of neurological symptoms among a total of 2533 hospitalized COVID-19 patients, and articles focusing on COVID-19 patients with neurological manifestations including a total of 580 patients. Neurological symptoms involved up to 73% of COVID-19 hospitalized patients, and were mostly headache, myalgias and impaired consciousness. Central nervous system (CNS) manifestations reported in COVID-19 were mostly non-specific encephalopathies that represented between 13% and 40% of all neurological manifestations; post-infectious syndromes including acute demyelinating encephalomyelitis (ADEM, n=13), acute necrotizing encephalopathy (ANE, n=4), Bickerstaff's encephalitis (n=5), generalized myoclonus (n=3) and acute transverse myelitis (n=7); other encephalitis including limbic encephalitis (n=9) and miscellaneous encephalitis with variable radiologic findings (n=26); acute cerebrovascular diseases including ischemic strokes (between 1.3% and 4.7% of COVID-19 patients), hemorrhagic strokes (n=17), cerebral venous thrombosis (n=8) and posterior reversible encephalopathy (n=5). Peripheral nervous system (PNS) manifestations reported in COVID-19 were the following: Guillain-Barré syndrome (n=31) and variants including Miller Fisher syndrome (n=3), polyneuritis cranialis (n=2) and facial diplegia (n=2); isolated oculomotor neuropathy (n=6); critical illness myopathy (n=6). Neuropathological studies in COVID-19 patients demonstrated different patterns of CNS damage, mostly ischemic and hemorrhagic changes with few cases of inflammatory injuries. Only one case suggested SARS-CoV-2 infiltration in endothelial and neural cells. We found 10 case reports or case series describing 22 patients with neurological manifestations associated with other human coronaviruses. Among them we found four MERS patients with ADEM or Bickerstaff's encephalitis, two SARS patients with encephalitis who had a positive SARS-CoV PCR in cerebrospinal fluid, five patients with ischemic strokes associated with SARS, eight MERS patients with critical illness neuromyopathy and one MERS patient with Guillain-Barré Syndrome. An autopsy study on SARS-CoV patients demonstrated the presence of the virus in the brain of eight patients.</AbstractText>
          <AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">The wide range of neurological manifestations and diseases associated with SARS-CoV-2 is consistent with multiple pathogenic pathways including post-infectious mechanisms, septic-associated encephalopathies, coagulopathy or endothelitis. There was no definite evidence to support direct neuropathogenicity of SARS-CoV-2.</AbstractText>
          <CopyrightInformation>Copyright © 2020 Elsevier Masson SAS. All rights reserved.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Maury</LastName>
            <ForeName>A</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Neurology, centre hospitalier de Saint-Denis, hôpital Delafontaine, 93200 Saint-Denis, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Lyoubi</LastName>
            <ForeName>A</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Neurology, centre hospitalier de Saint-Denis, hôpital Delafontaine, 93200 Saint-Denis, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Peiffer-Smadja</LastName>
            <ForeName>N</ForeName>
            <Initials>N</Initials>
            <AffiliationInfo>
              <Affiliation>National Institute for Health Research Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance, Imperial College London, London, UK; Inserm, IAME, Université de Paris, 75018 Paris, France; Infectious and Tropical Diseases Department, Bichat-Claude-Bernard Hospital, AP-HP, 75018 Paris, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>de Broucker</LastName>
            <ForeName>T</ForeName>
            <Initials>T</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Neurology, centre hospitalier de Saint-Denis, hôpital Delafontaine, 93200 Saint-Denis, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Meppiel</LastName>
            <ForeName>E</ForeName>
            <Initials>E</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Neurology, centre hospitalier de Saint-Denis, hôpital Delafontaine, 93200 Saint-Denis, France. Electronic address: elodie.meppiel@ch-stdenis.fr.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D016454">Review</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>12</Month>
          <Day>16</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Rev Neurol (Paris)</MedlineTA>
        <NlmUniqueID>2984779R</NlmUniqueID>
        <ISSNLinking>0035-3787</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D001927" MajorTopicYN="N">Brain Diseases</DescriptorName>
          <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
          <QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName>
          <QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D018352" MajorTopicYN="N">Coronavirus Infections</DescriptorName>
          <QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D028962" MajorTopicYN="N">Coronavirus OC43, Human</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D020275" MajorTopicYN="N">Guillain-Barre Syndrome</DescriptorName>
          <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
          <QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D065207" MajorTopicYN="N">Middle East Respiratory Syndrome Coronavirus</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D009187" MajorTopicYN="N">Myelitis</DescriptorName>
          <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
          <QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D009422" MajorTopicYN="N">Nervous System Diseases</DescriptorName>
          <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
          <QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000086402" MajorTopicYN="Y">SARS-CoV-2</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D045169" MajorTopicYN="N">Severe Acute Respiratory Syndrome</DescriptorName>
          <QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D020521" MajorTopicYN="N">Stroke</DescriptorName>
          <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
          <QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">COVID-19</Keyword>
        <Keyword MajorTopicYN="N">Coronaviruses</Keyword>
        <Keyword MajorTopicYN="N">Nervous System</Keyword>
        <Keyword MajorTopicYN="N">Neurological manifestations</Keyword>
        <Keyword MajorTopicYN="N">SARS-CoV-2</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2020</Year>
          <Month>8</Month>
          <Day>18</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2020</Year>
          <Month>10</Month>
          <Day>4</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2020</Year>
          <Month>10</Month>
          <Day>6</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2021</Year>
          <Month>1</Month>
          <Day>16</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2021</Year>
          <Month>2</Month>
          <Day>20</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2021</Year>
          <Month>1</Month>
          <Day>15</Day>
          <Hour>5</Hour>
          <Minute>37</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">33446327</ArticleId>
        <ArticleId IdType="pmc">PMC7832485</ArticleId>
        <ArticleId IdType="doi">10.1016/j.neurol.2020.10.001</ArticleId>
        <ArticleId IdType="pii">S0035-3787(20)30732-3</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>World Health Organization . 2020. WHO characterizes COVID-19 as a pandemic. [Published online March 11, 2020. Accessed March 14, 2020.  https://www.who.int/emergencies/diseases/novel-coronavirus-2019/events-as-they-happen]</Citation>
        </Reference>
        <Reference>
          <Citation>Mao L., Jin H., Wang M. Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China. JAMA Neurol. 2020;77(6):683–690. doi: 10.1001/jamaneurol.2020.1127.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1001/jamaneurol.2020.1127</ArticleId>
            <ArticleId IdType="pmc">PMC7149362</ArticleId>
            <ArticleId IdType="pubmed">32275288</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Romero-Sánchez C.M., Díaz-Maroto I., Fernández-Díaz E. Neurologic manifestations in hospitalized patients with COVID-19: the ALBACOVID registry. Neurology. 2020;95(8) doi: 10.1212/WNL.0000000000009937. e1060-e1070 [Published online June 1, 2020:10.1212/WNL. 0000000000009937]</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1212/WNL.0000000000009937</ArticleId>
            <ArticleId IdType="pmc">PMC7668545</ArticleId>
            <ArticleId IdType="pubmed">32482845</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mahammedi A., Saba L., Vagal A. Imaging in Neurological Disease of Hospitalized COVID-19 Patients: an Italian Multicenter Retrospective Observational Study. Radiology. 2020;297S(2) doi: 10.1148/radiol.2020201933. E270-E273.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1148/radiol.2020201933</ArticleId>
            <ArticleId IdType="pmc">PMC7587295</ArticleId>
            <ArticleId IdType="pubmed">32437313</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Guilmot A., Maldonado Slootjes S., Sellimi A. Immune-mediated neurological syndromes in SARS-CoV-2-infected patients. J Neurol. 2020:1–7. doi: 10.1007/s00415-020-10108-x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00415-020-10108-x</ArticleId>
            <ArticleId IdType="pmc">PMC7391231</ArticleId>
            <ArticleId IdType="pubmed">32734353</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Agarwal P., Ray S., Madan A., Tyson B. Neurological manifestations in 404 COVID-19 patients in Washington State. J Neurol. 2020 doi: 10.1007/s00415-020-10087-z. [Published online August 6, 2020]</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00415-020-10087-z</ArticleId>
            <ArticleId IdType="pmc">PMC7407444</ArticleId>
            <ArticleId IdType="pubmed">32761507</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Varatharaj A., Thomas N., Ellul M.A. Neurological and neuropsychiatric complications of COVID-19 in 153 patients: a UK-wide surveillance study. The Lancet Psychiatry. 2020;7(10):875–882. doi: 10.1016/S2215-0366(20)30287-X.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S2215-0366(20)30287-X</ArticleId>
            <ArticleId IdType="pmc">PMC7316461</ArticleId>
            <ArticleId IdType="pubmed">32593341</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Paterson R.W., Brown R.L., Benjamin L. The emerging spectrum of COVID-19 neurology: clinical, radiological and laboratory findings. Brain. 2020;143(10):3104–3120.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7454352</ArticleId>
            <ArticleId IdType="pubmed">32637987</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kremer S., Lersy F., Anheim M. Neurologic and neuroimaging findings in COVID-19 patients: A retrospective multicenter study. Neurology. 2020;95(13) doi: 10.1212/WNL.0000000000010112.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1212/WNL.0000000000010112</ArticleId>
            <ArticleId IdType="pubmed">32680942</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Meppiel E., Peiffer-Smadja N., Maury A. Neurologic manifestations associated with COVID-19: a multicentre registry. Clin Microbiol Infect. 2020 doi: 10.1016/j.cmi.2020.11.005. S1198-743X(20)30698-4.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.cmi.2020.11.005</ArticleId>
            <ArticleId IdType="pmc">PMC7661948</ArticleId>
            <ArticleId IdType="pubmed">33189873</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Helms J., Kremer S., Merdji H. Neurologic features in severe SARS-CoV-2 infection. N Engl J Med. 2020;382(23):2268–2270.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7179967</ArticleId>
            <ArticleId IdType="pubmed">32294339</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Brun G., Hak J.-F., Coze S. COVID-19 – White matter and globus pallidum lesions: demyelination or small-vessel vasculitis? Neurol Neuroimmunol Neuroinflamm. 2020;7(4):e777. doi: 10.1212/NXI.0000000000000777.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1212/NXI.0000000000000777</ArticleId>
            <ArticleId IdType="pmc">PMC7286652</ArticleId>
            <ArticleId IdType="pubmed">32444427</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hanafi R., Outteryck O. COVID-19 neurologic complication with CNS vasculitis-like pattern. AJNR Am J Neuroradiol. 2020;41(8):1384–1387.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7658880</ArticleId>
            <ArticleId IdType="pubmed">32554425</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Novi G., Rossi T., Pedemonte E. Acute disseminated encephalomyelitis after SARS-CoV-2 infection. Neurol Neuroimmunol Neuroinflamm. 2020;7(5):e797. doi: 10.1212/NXI.0000000000000797.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1212/NXI.0000000000000797</ArticleId>
            <ArticleId IdType="pmc">PMC7286650</ArticleId>
            <ArticleId IdType="pubmed">32482781</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dixon L., Varley J., Gontsarova A. COVID-19-related acute necrotizing encephalopathy with brain stem involvement in a patient with aplastic anemia. Neurol Neuroimmunol Neuroinflamm. 2020;7(5):e789. doi: 10.1212/NXI.0000000000000789.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1212/NXI.0000000000000789</ArticleId>
            <ArticleId IdType="pmc">PMC7286661</ArticleId>
            <ArticleId IdType="pubmed">32457227</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Poyiadji N., Shahin G., Noujaim D., Stone M., Patel S., Griffith B. COVID-19 – associated acute hemorrhagic necrotizing encephalopathy: CT and MRI features. Radiology. 2020:201187. doi: 10.1148/radiol.2020201187. [Published online March 31, 2020]</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1148/radiol.2020201187</ArticleId>
            <ArticleId IdType="pmc">PMC7233386</ArticleId>
            <ArticleId IdType="pubmed">32228363</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Efe I.E., Aydin O.U., Alabulut A., Celik O., Aydin K. COVID-19-associated encephalitis mimicking glial tumor. World Neurosurg. 2020;140:46–48. doi: 10.1016/j.wneu.2020.05.194.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.wneu.2020.05.194</ArticleId>
            <ArticleId IdType="pmc">PMC7256557</ArticleId>
            <ArticleId IdType="pubmed">32479911</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Moriguchi T., Harii N., Goto J. A first case of meningitis/encephalitis associated with SARS-Coronavirus-2. Int J Infect Dis. 2020;94:55–58. doi: 10.1016/j.ijid.2020.03.062.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ijid.2020.03.062</ArticleId>
            <ArticleId IdType="pmc">PMC7195378</ArticleId>
            <ArticleId IdType="pubmed">32251791</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wong P.F., Craik S., Newman P. Lessons of the month 1: a case of rhombencephalitis as a rare complication of acute COVID-19 infection. Clin Med (Lond) 2020 doi: 10.7861/clinmed.2020-0182. [Published online May 5, 2020]</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.7861/clinmed.2020-0182</ArticleId>
            <ArticleId IdType="pmc">PMC7354044</ArticleId>
            <ArticleId IdType="pubmed">32371417</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bernard-Valnet R., Pizzarotti B., Anichini A. Two patients with acute meningo-encephalitis concomitant to SARS-CoV-2 infection. Eur J Neurol. 2020 doi: 10.1111/ene.14298. [Published online May 7 2020]</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/ene.14298</ArticleId>
            <ArticleId IdType="pmc">PMC7267660</ArticleId>
            <ArticleId IdType="pubmed">32383343</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pilotto A., Odolini S., Masciocchi S. Steroid-responsive encephalitis in coronavirus disease 2019. Ann Neurol. 2020;88(2):423–427.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7276848</ArticleId>
            <ArticleId IdType="pubmed">32418288</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hayashi M., Sahashi Y., Baba Y., Okura H., Shimohata T. COVID-19-associated mild encephalitis/encephalopathy with a reversible splenial lesion. J Neurol Sci. 2020;415:116941. doi: 10.1016/j.jns.2020.116941.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jns.2020.116941</ArticleId>
            <ArticleId IdType="pmc">PMC7251406</ArticleId>
            <ArticleId IdType="pubmed">32474220</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Le Guennec L., Devianne J., Jalin L. Orbitofrontal involvement in a neuroCOVID-19 patient. Epilepsia. 2020 doi: 10.1111/epi.16612. [Published online June 26, 2020:epi.16612]</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/epi.16612</ArticleId>
            <ArticleId IdType="pmc">PMC7361605</ArticleId>
            <ArticleId IdType="pubmed">32589794</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zanin L., Saraceno G., Panciani P.P. SARS-CoV-2 can induce brain and spine demyelinating lesions. Acta Neurochir. 2020 doi: 10.1007/s00701-020-04374-x. [Published online May 4, 2020]</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00701-020-04374-x</ArticleId>
            <ArticleId IdType="pmc">PMC7197630</ArticleId>
            <ArticleId IdType="pubmed">32367205</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rábano-Suárez P., Bermejo-Guerrero L., Méndez-Guerrero A. Generalized myoclonus in COVID-19. Neurology. 2020;95(6) e767-e772.</Citation>
        </Reference>
        <Reference>
          <Citation>Méndez-Guerrero A., Laespada-García M.I., Gómez-Grande A. Acute hypokinetic-rigid syndrome following SARS-CoV-2 infection. Neurology. 2020 doi: 10.1212/WNL.0000000000010282. [Published online July 8, 2020:10.1212/WNL. 0000000000010282]</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1212/WNL.0000000000010282</ArticleId>
            <ArticleId IdType="pubmed">32641525</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cohen M.E., Eichel R., Steiner-Birmanns B. A case of probable Parkinson's disease after SARS-CoV-2 infection. Lancet Neurol. 2020;19(10):804–805. doi: 10.1016/S1474-4422(20)30305-7.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S1474-4422(20)30305-7</ArticleId>
            <ArticleId IdType="pmc">PMC7494295</ArticleId>
            <ArticleId IdType="pubmed">32949534</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pascual-Goñi E., Fortea J., Martínez-Domeño A. COVID-19-associated ophthalmoparesis and hypothalamic involvement. Neurol Neuroimmunol Neuroinflamm. 2020;7(5):e823. doi: 10.1212/NXI.0000000000000823.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1212/NXI.0000000000000823</ArticleId>
            <ArticleId IdType="pmc">PMC7357415</ArticleId>
            <ArticleId IdType="pubmed">32587102</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pugin D., Vargas M.-I., Thieffry C. COVID-19-related encephalopathy responsive to high doses glucocorticoids. Neurology. 2020 doi: 10.1212/WNL.0000000000010354. [Published online July 17, 2020:101212/WNL.0000000000010354]</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1212/WNL.0000000000010354</ArticleId>
            <ArticleId IdType="pubmed">32680950</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Vellieux G., Rouvel-Tallec A., Jaquet P., Grinea A., Sonneville R., d’Ortho M.-P. COVID-19 associated encephalopathy: is there a specific EEG pattern? Clin Neurophysiol. 2020;131(8):1928–1930. doi: 10.1016/j.clinph.2020.06.005.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.clinph.2020.06.005</ArticleId>
            <ArticleId IdType="pmc">PMC7311351</ArticleId>
            <ArticleId IdType="pubmed">32615526</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Vespignani H., Colas D., Lavin B.S. Report of EEG finding on critically ill patients with COVID-19. Ann Neurol. 2020 doi: 10.1002/ana.25814. [Published online June 13, 2020:ana.25814]</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/ana.25814</ArticleId>
            <ArticleId IdType="pmc">PMC7323170</ArticleId>
            <ArticleId IdType="pubmed">32533727</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Perrin P., Collongues N., Baloglu S. Cytokine release syndrome-associated encephalopathy in patients with COVID-19. Eur J Neurol. 2021;28(1):248–258. doi: 10.1111/ene.14491.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/ene.14491</ArticleId>
            <ArticleId IdType="pmc">PMC7461405</ArticleId>
            <ArticleId IdType="pubmed">32853434</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Delorme C., Paccoud O., Kas A. Covid-19-related encephalopathy: a case series with brain FDG-PET/CT findings. Eur J Neurol. 2020;27(12):2651–2657. doi: 10.1111/ene.14478.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/ene.14478</ArticleId>
            <ArticleId IdType="pmc">PMC7461074</ArticleId>
            <ArticleId IdType="pubmed">32881133</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>von Weyhern C.H., Kaufmann I., Neff F., Kremer M. Early evidence of pronounced brain involvement in fatal COVID-19 outcomes. Lancet. 2020 doi: 10.1016/S0140-6736(20)31282-4. [Published online June 2020:S0140673620312824]</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0140-6736(20)31282-4</ArticleId>
            <ArticleId IdType="pmc">PMC7272176</ArticleId>
            <ArticleId IdType="pubmed">32505222</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Solomon I.H., Normandin E., Bhattacharyya S. Neuropathological Features of COVID-19. N Engl J Med. 2020 doi: 10.1056/NEJMc2019373. [Published online June 12, 2020:NEJMc2019373]</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1056/NEJMc2019373</ArticleId>
            <ArticleId IdType="pmc">PMC7304421</ArticleId>
            <ArticleId IdType="pubmed">32530583</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Reichard R.R., Kashani K.B., Boire N.A., Constantopoulos E., Guo Y., Lucchinetti C.F. Neuropathology of COVID-19: a spectrum of vascular and acute disseminated encephalomyelitis (ADEM)-like pathology. Acta Neuropathol. 2020 doi: 10.1007/s00401-020-02166-2. [Published online May 24, 2020]</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00401-020-02166-2</ArticleId>
            <ArticleId IdType="pmc">PMC7245994</ArticleId>
            <ArticleId IdType="pubmed">32449057</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jaunmuktane Z., Mahadeva U., Green A. Microvascular injury and hypoxic damage: emerging neuropathological signatures in COVID-19. Acta Neuropathol. 2020;140(3):397–400. doi: 10.1007/s00401-020-02190-2.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00401-020-02190-2</ArticleId>
            <ArticleId IdType="pmc">PMC7340758</ArticleId>
            <ArticleId IdType="pubmed">32638079</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kantonen J., Mahzabin S., Mäyränpää M.I. Neuropathologic features of four autopsied COVID-19 patients. Brain Pathol. 2020;30(6):1012–1016. doi: 10.1111/bpa.12889.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/bpa.12889</ArticleId>
            <ArticleId IdType="pmc">PMC7436498</ArticleId>
            <ArticleId IdType="pubmed">32762083</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Deigendesch N., Sironi L., Kutza M. Correlates of critical illness-related encephalopathy predominate postmortem COVID-19 neuropathology. Acta Neuropathol. 2020;140(4):583–586. doi: 10.1007/s00401-020-02213-y.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00401-020-02213-y</ArticleId>
            <ArticleId IdType="pmc">PMC7449525</ArticleId>
            <ArticleId IdType="pubmed">32851506</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Paniz-Mondolfi A., Bryce C., Grimes Z. Central nervous system involvement by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) J Med Virol. 2020;92(7):699–702. doi: 10.1002/jmv.25915.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/jmv.25915</ArticleId>
            <ArticleId IdType="pmc">PMC7264598</ArticleId>
            <ArticleId IdType="pubmed">32314810</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Moore J.B., June C.H. Cytokine release syndrome in severe COVID-19. Science. 2020;368(6490):473–474. doi: 10.1126/science.abb8925.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1126/science.abb8925</ArticleId>
            <ArticleId IdType="pubmed">32303591</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mazeraud A., Righy C., Bouchereau E., Benghanem S., Bozza F.A., Sharshar T. Septic-associated encephalopathy: a comprehensive review. Neurotherapeutics. 2020 doi: 10.1007/s13311-020-00862-1. [Published online May 6, 2020]</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s13311-020-00862-1</ArticleId>
            <ArticleId IdType="pmc">PMC7283452</ArticleId>
            <ArticleId IdType="pubmed">32378026</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Racchiusa S., Mormina E., Ax A., Musumeci O., Longo M., Granata F. Posterior reversible encephalopathy syndrome (PRES) and infection: a systematic review of the literature. Neurol Sci. 2019;40(5):915–922. doi: 10.1007/s10072-018-3651-4.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s10072-018-3651-4</ArticleId>
            <ArticleId IdType="pubmed">30604335</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Franceschi A.M., Ahmed O., Giliberto L., Castillo M. Hemorrhagic posterior reversible encephalopathy syndrome as a manifestation of COVID-19 infection. Am J Neuroradiol. 2020 doi: 10.3174/ajnr.A6595. [Published online May 21, 2020]</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3174/ajnr.A6595</ArticleId>
            <ArticleId IdType="pmc">PMC7357664</ArticleId>
            <ArticleId IdType="pubmed">32439646</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gaur P., Dixon L., Jones B., Lyall H., Jan W. COVID-19-associated cytotoxic lesions of the corpus callosum. Am J Neuroradiol. 2020 doi: 10.3174/ajnr.A6713. [Published online August 20, 2020]</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3174/ajnr.A6713</ArticleId>
            <ArticleId IdType="pmc">PMC7661087</ArticleId>
            <ArticleId IdType="pubmed">32819904</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lin J., Lawson E.C., Verma S., Peterson R.B., Sidhu R. Cytotoxic lesion of the corpus callosum in an adolescent with multisystem inflammatory syndrome and SARS-CoV-2 infection. Am J Neuroradiol. 2020 doi: 10.3174/ajnr.A6755. [Published online August 20, 2020]</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3174/ajnr.A6755</ArticleId>
            <ArticleId IdType="pmc">PMC7658840</ArticleId>
            <ArticleId IdType="pubmed">32819898</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Abdel-Mannan O., Eyre M., Löbel U. Neurologic and radiographic findings associated with COVID-19 infection in children. JAMA Neurol. 2020 doi: 10.1001/jamaneurol.2020.2687. [Published online July 1, 2020]</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1001/jamaneurol.2020.2687</ArticleId>
            <ArticleId IdType="pmc">PMC7330822</ArticleId>
            <ArticleId IdType="pubmed">32609336</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Varga Z., Flammer A.J., Steiger P. Endothelial cell infection and endotheliitis in COVID-19. Lancet. 2020;395(10234):1417–1418. doi: 10.1016/S0140-6736(20)30937-5.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0140-6736(20)30937-5</ArticleId>
            <ArticleId IdType="pmc">PMC7172722</ArticleId>
            <ArticleId IdType="pubmed">32325026</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>AlKetbi R., AlNuaimi D., AlMulla M., AlTalai N., Samir M., Kumar N. Acute myelitis as a neurological complication of COVID-19: a case report and MRI findings. Radiol Case Rep. 2020 doi: 10.1016/j.radcr.2020.06.001. [Published online June 6, 2020]</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.radcr.2020.06.001</ArticleId>
            <ArticleId IdType="pmc">PMC7275163</ArticleId>
            <ArticleId IdType="pubmed">32685076</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Durrani M., Kucharski K., Smith Z., Fien S. Acute Transverse Myelitis Secondary to Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): A Case Report. Clin Pract Cases Emerg Med. 2020;4(3):344–348. doi: 10.5811/cpcem.2020.6.48462.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.5811/cpcem.2020.6.48462</ArticleId>
            <ArticleId IdType="pmc">PMC7434243</ArticleId>
            <ArticleId IdType="pubmed">32926682</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Munz M., Wessendorf S., Koretsis G. Acute transverse myelitis after COVID-19 pneumonia. J Neurol. 2020 doi: 10.1007/s00415-020-09934-w. [Published online May 26, 2020]</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00415-020-09934-w</ArticleId>
            <ArticleId IdType="pmc">PMC7250275</ArticleId>
            <ArticleId IdType="pubmed">32458198</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sarma D., Bilello L.A. A Case Report of Acute Transverse Myelitis Following Novel Coronavirus Infection. Clin Pract Cases Emerg Med. 2020;4(3):321–323. doi: 10.5811/cpcem.2020.5.47937.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.5811/cpcem.2020.5.47937</ArticleId>
            <ArticleId IdType="pmc">PMC7434287</ArticleId>
            <ArticleId IdType="pubmed">32926676</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sotoca J., Rodríguez-Álvarez Y. COVID-19-associated acute necrotizing myelitis. Neurol Neuroimmunol Neuroinflamm. 2020;7(5):e803. doi: 10.1212/NXI.0000000000000803.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1212/NXI.0000000000000803</ArticleId>
            <ArticleId IdType="pmc">PMC7309521</ArticleId>
            <ArticleId IdType="pubmed">32522767</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Valiuddin H., Skwirsk B., Paz-Arabo P. Acute transverse myelitis associated with SARS-CoV-2: a case-report. Brain Behav Immun Health. 2020;5:100091. doi: 10.1016/j.bbih.2020.100091.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.bbih.2020.100091</ArticleId>
            <ArticleId IdType="pmc">PMC7275168</ArticleId>
            <ArticleId IdType="pubmed">32835294</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Aguiar de Sousa D., Sandset Else C., Elkind Mitchell S.V. The curious case of the missing strokes during the COVID-19 pandemic. Stroke. 2020;51(7):1921–1923. doi: 10.1161/STROKEAHA.120.030792.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1161/STROKEAHA.120.030792</ArticleId>
            <ArticleId IdType="pmc">PMC7282410</ArticleId>
            <ArticleId IdType="pubmed">32466737</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Merkler A.E., Parikh N.S., Mir S. Risk of Ischemic Stroke in Patients With Coronavirus Disease 2019 (COVID-19) vs. Patients With Influenza. JAMA Neurol. 2020 doi: 10.1001/jamaneurol.2020.2730. [Published online July 2, 2020]</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1001/jamaneurol.2020.2730</ArticleId>
            <ArticleId IdType="pmc">PMC7333175</ArticleId>
            <ArticleId IdType="pubmed">32614385</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hernández-Fernández F., Valencia H.S., Barbella-Aponte R.A. Cerebrovascular disease in patients with COVID-19: neuroimaging, histological and clinical description. Brain. 2020;143(10):3089–3103. doi: 10.1093/brain/awaa239.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/brain/awaa239</ArticleId>
            <ArticleId IdType="pmc">PMC7454411</ArticleId>
            <ArticleId IdType="pubmed">32645151</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Avula A., Nalleballe K., Narula N. COVID-19 presenting as stroke. Brain Behav Immun. 2020 doi: 10.1016/j.bbi.2020.04.077. [Published online April 28, 2020]</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.bbi.2020.04.077</ArticleId>
            <ArticleId IdType="pmc">PMC7187846</ArticleId>
            <ArticleId IdType="pubmed">32360439</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Beyrouti R., Adams M.E., Benjamin L. Characteristics of ischaemic stroke associated with COVID-19. J Neurol Neurosurg Psychiatry. 2020 doi: 10.1136/jnnp-2020-323586. [Published online April 30, 2020:jnnp-2020-323586]</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/jnnp-2020-323586</ArticleId>
            <ArticleId IdType="pmc">PMC7231545</ArticleId>
            <ArticleId IdType="pubmed">32354768</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fara M.G., Stein L.K., Skliut M., Morgello S., Fifi J.T., Dhamoon M.S. Macrothrombosis and stroke in patients with mild Covid-19 infection. J Thromb Haemost. 2020;18(8):2031–2033. doi: 10.1111/jth.14938.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/jth.14938</ArticleId>
            <ArticleId IdType="pmc">PMC7283879</ArticleId>
            <ArticleId IdType="pubmed">32464707</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Morassi M., Bagatto D., Cobelli M. Stroke in patients with SARS-CoV-2 infection: case series. J Neurol. 2020 doi: 10.1007/s00415-020-09885-2. [Published online May 20, 2020]</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00415-020-09885-2</ArticleId>
            <ArticleId IdType="pmc">PMC7238403</ArticleId>
            <ArticleId IdType="pubmed">32436105</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Oxley T.J., Mocco J., Majidi S. Large-vessel stroke as a presenting feature of COVID-19 in the young. N Engl J Med. 2020 doi: 10.1056/NEJMc2009787. [Published online April 28, 2020:e60]</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1056/NEJMc2009787</ArticleId>
            <ArticleId IdType="pmc">PMC7207073</ArticleId>
            <ArticleId IdType="pubmed">32343504</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhang Y., Xiao M., Zhang S. Coagulopathy and antiphospholipid antibodies in patients with COVID-19. N Engl J Med. 2020;382(17):e38. doi: 10.1056/NEJMc2007575.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1056/NEJMc2007575</ArticleId>
            <ArticleId IdType="pmc">PMC7161262</ArticleId>
            <ArticleId IdType="pubmed">32268022</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Morassi M., Bigni B., Cobelli M., Giudice L., Bnà C., Vogrig A. Bilateral carotid artery dissection in a SARS-CoV-2 infected patient: causality or coincidence? J Neurol. 2020 doi: 10.1007/s00415-020-09984-0. [Published online June 12, 2020]</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00415-020-09984-0</ArticleId>
            <ArticleId IdType="pmc">PMC7292240</ArticleId>
            <ArticleId IdType="pubmed">32533323</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mirzaee S.M.M., Gonçalves F.G., Mohammadifard M., Tavakoli S.M., Vossough A. Focal cerebral arteriopathy in a COVID-19 PEDIATRIC PATient. Radiology. 2020 doi: 10.1148/radiol.2020202197. [Published online June 2, 2020:202197]</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1148/radiol.2020202197</ArticleId>
            <ArticleId IdType="pmc">PMC7587294</ArticleId>
            <ArticleId IdType="pubmed">32484418</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ntaios George, Michel Patrik, Georgiopoulos Georgios Characteristics and outcomes in patients with COVID-19 and acute ischemic stroke. Stroke. 2020;51(9):e254–e258. doi: 10.1161/STROKEAHA.120.031208.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1161/STROKEAHA.120.031208</ArticleId>
            <ArticleId IdType="pmc">PMC7359900</ArticleId>
            <ArticleId IdType="pubmed">32787707</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yaghi S., Ishida K., Torres J. SARS2-CoV-2 and Stroke in a New York Healthcare System. Stroke. 2020 doi: 10.1161/STROKEAHA.120.030335. [Published online May 20, 2020:STROKEAHA120030335]</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1161/STROKEAHA.120.030335</ArticleId>
            <ArticleId IdType="pmc">PMC7258764</ArticleId>
            <ArticleId IdType="pubmed">32432996</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tang N., Li D., Wang X., Sun Z. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J Thromb Haemost. 2020;18(4):844–847. doi: 10.1111/jth.14768.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/jth.14768</ArticleId>
            <ArticleId IdType="pmc">PMC7166509</ArticleId>
            <ArticleId IdType="pubmed">32073213</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zheng Y.-Y., Ma Y.-T., Zhang J.-Y., Xie X. COVID-19 and the cardiovascular system. Nat Rev Cardiol. 2020;17(5):259–260. doi: 10.1038/s41569-020-0360-5.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/s41569-020-0360-5</ArticleId>
            <ArticleId IdType="pmc">PMC7095524</ArticleId>
            <ArticleId IdType="pubmed">32139904</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>García-García S., Cepeda S., Arrese I., Sarabia R., Letter: Hemorrhagic conditions affecting the central nervous system in COVID-19 patients. Neurosurgery. 2020 doi: 10.1093/neuros/nyaa253. [Published online June 3, 2020]</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/neuros/nyaa253</ArticleId>
            <ArticleId IdType="pmc">PMC7313785</ArticleId>
            <ArticleId IdType="pubmed">32490520</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Al-olama M., Rashid A., Garozzo D. COVID-19-associated meningoencephalitis complicated with intracranial hemorrhage: a case report. Acta Neurochir. 2020 doi: 10.1007/s00701-020-04402-w. [Published online May 20, 2020]</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00701-020-04402-w</ArticleId>
            <ArticleId IdType="pmc">PMC7237227</ArticleId>
            <ArticleId IdType="pubmed">32430637</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kaya Y., Kara S., Akinci C., Kocaman A.S. Transient cortical blindness in COVID-19 pneumonia; a PRES-like syndrome: a case report. J Neurol Sci. 2020 doi: 10.1016/j.jns.2020.116858. [Published online April 28, 2020]</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jns.2020.116858</ArticleId>
            <ArticleId IdType="pmc">PMC7187859</ArticleId>
            <ArticleId IdType="pubmed">32387762</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kishfy L., Casasola M., Banankhah P. Posterior reversible encephalopathy syndrome in severe SARS-COV-2 infection. J Neurol Sci. 2020 doi: 10.1016/j.jns.2020.116943. [Published online May 23, 2020]</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jns.2020.116943</ArticleId>
            <ArticleId IdType="pmc">PMC7245308</ArticleId>
            <ArticleId IdType="pubmed">32474362</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lu L., Xiong W., Liu D. New onset acute symptomatic seizure and risk factors in coronavirus disease 2019: a retrospective multicenter study. Epilepsia. 2020 doi: 10.1111/epi.16524. [Published online April 18, 2020]</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/epi.16524</ArticleId>
            <ArticleId IdType="pmc">PMC7264627</ArticleId>
            <ArticleId IdType="pubmed">32304092</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Louis S., Dhawan A., Newey C. Continuous electroencephalography characteristics and acute symptomatic seizures in COVID-19 patients. Clin Neurophysiol. 2020;131(11):2651–2656. doi: 10.1016/j.clinph.2020.08.003.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.clinph.2020.08.003</ArticleId>
            <ArticleId IdType="pmc">PMC7448875</ArticleId>
            <ArticleId IdType="pubmed">32949985</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gigli G.L., Bax F., Marini A. Guillain–Barré syndrome in the COVID-19 era: just an occasional cluster? J Neurol. 2020 doi: 10.1007/s00415-020-09911-3. [Published online May 19, 2020]</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00415-020-09911-3</ArticleId>
            <ArticleId IdType="pmc">PMC7236438</ArticleId>
            <ArticleId IdType="pubmed">32430572</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Alberti P., Beretta S., Piatti M. Guillain-Barré syndrome related to COVID-19 infection. Neurol Neuroimmunol Neuroinflamm. 2020;7(4):e741. doi: 10.1212/NXI.0000000000000741.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1212/NXI.0000000000000741</ArticleId>
            <ArticleId IdType="pmc">PMC7217652</ArticleId>
            <ArticleId IdType="pubmed">32350026</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Arnaud S., Budowski C., Ng Wing Tin S., Degos B. Post SARS-CoV-2 Guillain–Barré syndrome. Clin Neurophysiol. 2020;131(7):1652–1654. doi: 10.1016/j.clinph.2020.05.003.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.clinph.2020.05.003</ArticleId>
            <ArticleId IdType="pmc">PMC7212990</ArticleId>
            <ArticleId IdType="pubmed">32422529</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bigaut K., Mallaret M., Baloglu S. Guillain-Barré syndrome related to SARS-CoV-2 infection. Neurol Neuroimmunol Neuroinflamm. 2020;7(5):e785. doi: 10.1212/NXI.0000000000000785.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1212/NXI.0000000000000785</ArticleId>
            <ArticleId IdType="pmc">PMC7286648</ArticleId>
            <ArticleId IdType="pubmed">32461235</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Camdessanche J.-P., Morel J., Pozzetto B., Paul S., Tholance Y., Botelho-Nevers E. COVID-19 may induce Guillain-Barré syndrome. Rev Neurol (Paris) 2020 doi: 10.1016/j.neurol.2020.04.003. [Published online April 15, 2020]</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.neurol.2020.04.003</ArticleId>
            <ArticleId IdType="pmc">PMC7158797</ArticleId>
            <ArticleId IdType="pubmed">32334841</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Coen M., Jeanson G., Culebras Almeida L.A. Guillain-Barré syndrome as a complication of SARS-CoV-2 infection. Brain Behav Immun. 2020;87:111–112. doi: 10.1016/j.bbi.2020.04.074.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.bbi.2020.04.074</ArticleId>
            <ArticleId IdType="pmc">PMC7194931</ArticleId>
            <ArticleId IdType="pubmed">32360440</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ottaviani D., Boso F., Tranquillini E. Early Guillain-Barré syndrome in coronavirus disease 2019 (COVID-19): a case report from an Italian COVID-hospital. Neurol Sci. 2020;41(6):1351–1354. doi: 10.1007/s10072-020-04449-8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s10072-020-04449-8</ArticleId>
            <ArticleId IdType="pmc">PMC7216127</ArticleId>
            <ArticleId IdType="pubmed">32399950</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Padroni M., Mastrangelo V., Asioli G.M. Guillain–Barré syndrome following COVID-19: new infection, old complication? J Neurol. 2020 doi: 10.1007/s00415-020-09849-6. [Published online April 24, 2020]</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00415-020-09849-6</ArticleId>
            <ArticleId IdType="pmc">PMC7180646</ArticleId>
            <ArticleId IdType="pubmed">32333166</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pfefferkorn T., Dabitz R., von Wernitz-Keibel T., Aufenanger J., Nowak-Machen M., Janssen H. Acute polyradiculoneuritis with locked-in syndrome in a patient with COVID-19. J Neurol. 2020 doi: 10.1007/s00415-020-09897-y. [Published online May 12, 2020]</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00415-020-09897-y</ArticleId>
            <ArticleId IdType="pmc">PMC7216124</ArticleId>
            <ArticleId IdType="pubmed">32399694</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Scheidl E., Canseco D.D., Hadji-Naumov A., Bereznai B. Guillain-Barre syndrome during SARS-CoV-2 pandemic: a case report and review of recent literature. J Peripher Nerv Syst. 2020;25(2):204–207. doi: 10.1111/jns.12382.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/jns.12382</ArticleId>
            <ArticleId IdType="pmc">PMC7273104</ArticleId>
            <ArticleId IdType="pubmed">32388880</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sedaghat Z., Karimi N. Guillain Barre syndrome associated with COVID-19 infection: a case report. J Clin Neurosci. 2020 doi: 10.1016/j.jocn.2020.04.062. [Published online April 15, 2020]</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jocn.2020.04.062</ArticleId>
            <ArticleId IdType="pmc">PMC7158817</ArticleId>
            <ArticleId IdType="pubmed">32312628</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Toscano G., Palmerini F., Ravaglia S. Guillain–Barré syndrome associated with SARS-CoV-2. N Engl J Med. 2020 doi: 10.1056/NEJMc2009191. [Published online April 17, 2020:NEJMc2009191]</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1056/NEJMc2009191</ArticleId>
            <ArticleId IdType="pmc">PMC7182017</ArticleId>
            <ArticleId IdType="pubmed">32302082</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Virani A., Rabold E., Hanson T. Guillain–Barré Syndrome associated with SARS-CoV-2 infection. IDCases. 2020;20:e00771. doi: 10.1016/j.idcr.2020.e00771.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.idcr.2020.e00771</ArticleId>
            <ArticleId IdType="pmc">PMC7165113</ArticleId>
            <ArticleId IdType="pubmed">32313807</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dinkin M., Gao V., Kahan J. COVID-19 presenting with ophthalmoparesis from cranial nerve palsy. Neurology. 2020 doi: 10.1212/WNL.0000000000009700. [Published online May 1, 2020]</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1212/WNL.0000000000009700</ArticleId>
            <ArticleId IdType="pubmed">32358218</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gutiérrez-Ortiz C., Méndez A., Rodrigo-Rey S. Miller Fisher Syndrome and polyneuritis cranialis in COVID-19. Neurology. 2020 [Published online April 17, 2020]</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">32303650</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Juliao Caamaño D.S., Alonso Beato R. Facial diplegia, a possible atypical variant of Guillain–Barré Syndrome as a rare neurological complication of SARS-CoV-2. J Clin Neurosci. 2020 doi: 10.1016/j.jocn.2020.05.016. [Published online May 14, 2020]</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jocn.2020.05.016</ArticleId>
            <ArticleId IdType="pmc">PMC7221378</ArticleId>
            <ArticleId IdType="pubmed">32410788</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wei H., Yin H., Huang M., Guo Z. The 2019 novel cornoavirus pneumonia with onset of oculomotor nerve palsy: a case study. J Neurol. 2020;267(5):1550–1553. doi: 10.1007/s00415-020-09773-9.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00415-020-09773-9</ArticleId>
            <ArticleId IdType="pmc">PMC7087661</ArticleId>
            <ArticleId IdType="pubmed">32100124</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Madia F., Merico B., Primiano G., Cutuli S.L., De Pascale G., Servidei S. Acute myopathic quadriplegia in COVID-19 patients in the intensive care unit. Neurology. 2020 [Published online June 29, 2020:10.1212/WNL.0000000000010280]</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">32601119</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Giacomelli A., Pezzati L., Conti F. Self-reported olfactory and taste disorders in SARS-CoV-2 patients: a cross-sectional study. Clin Infect Dis. 2020 doi: 10.1093/cid/ciaa330. [Published online March 26, 2020]</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/cid/ciaa330</ArticleId>
            <ArticleId IdType="pmc">PMC7184514</ArticleId>
            <ArticleId IdType="pubmed">32215618</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lechien J.R., Chiesa-Estomba C.M., De Siati D.R. Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): a multicenter European study. Eur Arch Otorhinolaryngol. 2020 doi: 10.1007/s00405-020-05965-1. [Published online April 6, 2020]</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00405-020-05965-1</ArticleId>
            <ArticleId IdType="pmc">PMC7134551</ArticleId>
            <ArticleId IdType="pubmed">32253535</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bénézit F., Turnier P.L., Declerck C. Utility of hyposmia and hypogeusia for the diagnosis of COVID-19. Lancet Infect Dis. 2020;20(9):1014–1015. doi: 10.1016/S1473-3099(20)30297-8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S1473-3099(20)30297-8</ArticleId>
            <ArticleId IdType="pmc">PMC7159866</ArticleId>
            <ArticleId IdType="pubmed">32304632</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lau K.-K., Yu W.-C., Chu C.-M., Lau S.-T., Sheng B., Yuen K.-Y. Possible central nervous system infection by SARS coronavirus. Emerging Infect Dis. 2004;10(2):342–344. doi: 10.3201/eid1002.030638.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3201/eid1002.030638</ArticleId>
            <ArticleId IdType="pmc">PMC3322928</ArticleId>
            <ArticleId IdType="pubmed">15030709</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hung E.C.W., Chim S.S.C., Chan P.K.S. Detection of SARS coronavirus RNA in the cerebrospinal fluid of a patient with severe acute respiratory syndrome. Clin Chem. 2003;49(12):2108–2109. doi: 10.1373/clinchem.2003.025437.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1373/clinchem.2003.025437</ArticleId>
            <ArticleId IdType="pmc">PMC7108123</ArticleId>
            <ArticleId IdType="pubmed">14633896</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Arabi Y.M., Harthi A., Hussein J. Severe neurologic syndrome associated with Middle East respiratory syndrome corona virus (MERS-CoV) Infection. 2015;43(4):495–501. doi: 10.1007/s15010-015-0720-y.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s15010-015-0720-y</ArticleId>
            <ArticleId IdType="pmc">PMC4521086</ArticleId>
            <ArticleId IdType="pubmed">25600929</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kim J.-E., Heo J.-H., Kim H. Neurological complications during treatment of middle east respiratory syndrome. J Clin Neurol. 2017;13(3):227. doi: 10.3988/jcn.2017.13.3.227.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3988/jcn.2017.13.3.227</ArticleId>
            <ArticleId IdType="pmc">PMC5532318</ArticleId>
            <ArticleId IdType="pubmed">28748673</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yeh E.A., Collins A., Cohen M.E., Duffner P.K., Faden H. Detection of coronavirus in the central nervous system of a child with acute disseminated encephalomyelitis. Pediatrics. 2004;113(1 Pt 1):e73–e76. doi: 10.1542/peds.113.1.e73.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1542/peds.113.1.e73</ArticleId>
            <ArticleId IdType="pubmed">14702500</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Umapathi T., Kor A.C., Venketasubramanian N. Large artery ischaemic stroke in severe acute respiratory syndrome (SARS) J Neurol. 2004;251(10):1227–1231. doi: 10.1007/s00415-004-0519-8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00415-004-0519-8</ArticleId>
            <ArticleId IdType="pmc">PMC7088071</ArticleId>
            <ArticleId IdType="pubmed">15503102</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Algahtani H., Subahi A., Shirah B. Neurological complications of Middle East respiratory syndrome coronavirus: a report of two cases and review of the literature. Case Rep Neurol Med. 2016:2016. doi: 10.1155/2016/3502683.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1155/2016/3502683</ArticleId>
            <ArticleId IdType="pmc">PMC4864560</ArticleId>
            <ArticleId IdType="pubmed">27239356</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Al-Hameed F.M. Spontaneous intracranial hemorrhage in a patient with Middle East respiratory syndrome corona virus. Saudi Med J. 2017;38(2):196–200. doi: 10.15537/smj.2017.2.16255.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.15537/smj.2017.2.16255</ArticleId>
            <ArticleId IdType="pmc">PMC5329633</ArticleId>
            <ArticleId IdType="pubmed">28133694</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tsai L.-K., Hsieh S.-T., Chao C.-C. Neuromuscular disorders in severe acute respiratory syndrome. Arch Neurol. 2004;61(11):1669–1673. doi: 10.1001/archneur.61.11.1669.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1001/archneur.61.11.1669</ArticleId>
            <ArticleId IdType="pubmed">15534177</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gu J., Gong E., Zhang B. Multiple organ infection and the pathogenesis of SARS. J Exp Med. 2005;202(3):415–424. doi: 10.1084/jem.20050828.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1084/jem.20050828</ArticleId>
            <ArticleId IdType="pmc">PMC2213088</ArticleId>
            <ArticleId IdType="pubmed">16043521</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Arbour N., Day R., Newcombe J., Talbot P.J. Neuroinvasion by human respiratory coronaviruses. J Virol. 2000;74(19):8913–8921. doi: 10.1128/JVI.74.19.8913-8921.2000.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/JVI.74.19.8913-8921.2000</ArticleId>
            <ArticleId IdType="pmc">PMC102086</ArticleId>
            <ArticleId IdType="pubmed">10982334</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
